Supernus Pharma (SUPN) Misses Q3 EPS by 94c
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Join SI Premium – FREE
Supernus Pharma (NASDAQ: SUPN) reported Q3 EPS of ($0.80), $0.94 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $192.1 million versus the consensus estimate of $175.82 million.
For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UGI shares spike on reported KKR bid for the company
- Infleqtion opens new Colorado headquarters for quantum work
- WaterBridge Infrastructure (WBI) PT Raised to $40 at Raymond James
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
